Methods to Evaluate the Antiobesity Effects of Medicinal Plants Using Enzyme Assays

Obesities Pub Date : 2023-01-19 DOI:10.3390/obesities3010003
S. Bandara, Shelby Devereaux, A. Weerasooriya
{"title":"Methods to Evaluate the Antiobesity Effects of Medicinal Plants Using Enzyme Assays","authors":"S. Bandara, Shelby Devereaux, A. Weerasooriya","doi":"10.3390/obesities3010003","DOIUrl":null,"url":null,"abstract":"Obesity is a chronic disease affecting both adults and children worldwide. One major cause of obesity is high-calorie intake due to overconsumption of foods rich in fat and carbohydrates. Hence, obesity can be controlled by controlling the diet and by other lifestyle changes that increase energy expenditure. However, this is not always possible for individuals who are already overweight and suffering from other diseases. Therefore, certain drugs have been developed to assist with weight reduction. One major avenue for drug development involves the inhibition of enzymes that break down fat and carbohydrates from the diet. This can reduce the bioavailability and absorption of dietary lipids and carbohydrates, allowing for the management of obesity. Although there are synthetic drugs available on the market to inhibit these enzymes, plant-based natural drugs may provide a better alternative to treat obesity due to fewer side effects and a lower cost. In this review, different methods that can be used to screen medicinal plant extracts for inhibitors of those digestive enzymes and certain limitations of those methods are discussed. Currently, there is limited research on the effects of varying conditions on enzyme assays, and this is an area that can be addressed in future research.","PeriodicalId":93598,"journal":{"name":"Obesities","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obesities","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/obesities3010003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Obesity is a chronic disease affecting both adults and children worldwide. One major cause of obesity is high-calorie intake due to overconsumption of foods rich in fat and carbohydrates. Hence, obesity can be controlled by controlling the diet and by other lifestyle changes that increase energy expenditure. However, this is not always possible for individuals who are already overweight and suffering from other diseases. Therefore, certain drugs have been developed to assist with weight reduction. One major avenue for drug development involves the inhibition of enzymes that break down fat and carbohydrates from the diet. This can reduce the bioavailability and absorption of dietary lipids and carbohydrates, allowing for the management of obesity. Although there are synthetic drugs available on the market to inhibit these enzymes, plant-based natural drugs may provide a better alternative to treat obesity due to fewer side effects and a lower cost. In this review, different methods that can be used to screen medicinal plant extracts for inhibitors of those digestive enzymes and certain limitations of those methods are discussed. Currently, there is limited research on the effects of varying conditions on enzyme assays, and this is an area that can be addressed in future research.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
方法采用酶法评价药用植物的抗肥胖作用
肥胖是一种影响全世界成人和儿童的慢性疾病。肥胖的一个主要原因是由于过度摄入富含脂肪和碳水化合物的食物而导致的高热量摄入。因此,肥胖可以通过控制饮食和其他增加能量消耗的生活方式改变来控制。然而,对于已经超重并患有其他疾病的人来说,这并不总是可能的。因此,已经开发出某些药物来帮助减轻体重。药物开发的一个主要途径是抑制分解饮食中脂肪和碳水化合物的酶。这可以降低膳食脂质和碳水化合物的生物利用度和吸收,从而有助于控制肥胖。尽管市场上有合成药物可以抑制这些酶,但由于副作用较少且成本较低,植物性天然药物可能为治疗肥胖提供更好的替代品。在这篇综述中,讨论了可用于筛选药用植物提取物中这些消化酶抑制剂的不同方法以及这些方法的某些局限性。目前,关于不同条件对酶测定的影响的研究有限,这是一个可以在未来研究中解决的领域。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Comparison of In-Person and Virtual Implementations of an Obesity Prevention Culinary Nutrition Education Program for Family Care Providers. Silymarin: A Natural Compound for Obesity Management Childhood and Adolescent Obesity in a School in Interior Portugal—A Teen without Risk Study Effectiveness of an Email-Based, Semaglutide-Supported Weight-Loss Service for People with Overweight and Obesity in Germany: A Real-World Retrospective Cohort Analysis The Metabolic Syndrome: An Overview and Proposed Mechanisms
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1